AzTrials
AzTrials

SciaticaECHORACHISNCT01832844

Effects of Control Scan for Presumed Difficult Epidural Infiltrations (ECHORACHIS)

A study testing Group " with scan prior to infiltration " and Group " without scan " in people with Sciatica, run by Nantes University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this care protocol is to study the effects of scan to help epidural infiltration realization, in presumed difficult patients suffering from sciatica. These scans are already performed in our Rheumatology Department but our objective is to evaluate objectively its contribution for patients and doctors. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sciatica
What is being tested?
Group " with scan prior to infiltration " and Group " without scan "
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
80 participants
Where
1 siteFrance
Study dates
Apr 2013to Jan 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Major patients hospitalized in Rheumatology Department for performing their first epidural infiltration when sciatica is resistant to medical treatment.
  • Inclusion of patients older than 60 years and / or BMI superior to 30 and / or scoliosis

Who cannot join

  • Refusal to participate
  • History of spinal surgery
  • Anticoagulant or antiplatelet
  • History of spinal malformations type spina bifida
  • pregnancy
  • Age<18
Show all 9Show fewer
  • Patients under guardianship
  • Patients participating to another clinical trial (except non interventional trials)
  • Patients unable to achieve the protocol, in the judgment of the investigator

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital

    Nantes, 44000

Other trials in France

About this study

Official title: Effects of Scan Control for Presumed Difficult Epidural Infiltrations: a Monocentric, Prospective, Randomized, Controlled, Simple Blind Trial

The aim of this care protocol is to study the effects of scan to help epidural infiltration realization, in presumed difficult patients suffering from sciatica.

These scans are already performed in our Rheumatology Department but our objective is to evaluate objectively its contribution for patients and doctors.

Read more

Epidural infiltration in young patients, with an easy anatomical identification, causes generally no technical difficulties, therefore this protocol will only include patients presumed to have a difficult infiltration, that means those aged more than 60, and/or with BMI > 30 and/or suffering from scoliosis.

This study concerns patients who are hospitalized in Rheumatology Department (Hospital of Nantes) for their first epidural infiltration for treatment-resistant lombosciatica.

Patient will be randomized at Day 0, before infiltration. This latter will be performed in accordance to current practice.

Tolerance data (pain and satisfaction) will be collected just after the infiltration and eventual complications will be reported within 48 hours after infiltration.

Following treatment of lombosciatic will be realized through hospitalization, as usual.

Scan is a safe, non invasive, painless and non radiating exam. It is the extension of the musculoskeletal clinical exam and it has already changed our rheumatology practices. The investigators hope at the end of this study, that results would confirm that scan can be a help in practice to perform epidural infiltrations.

Conditions
Sciatica
Being tested
Group " with scan prior to infiltration ", Group " without scan "
Keywords
Scan control, Epidural infiltration, visual analogue scale (VAS)
Medical subject headings
Sciatica

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group " with scan prior to infiltration "Procedure or surgery

    Scan will be conducted by the operator performing the gesture. He will examine the lumbar spine from L3 to S1, in longitudinal and cross sections and determine the best surgical approach. This will be defined by the largest interspinous space or better visibility of the epidural space. The depth of the epidural space will be noted. The selected stage will be marked with a skin pen to facilitate its location thereafter

  • Group " without scan "Procedure or surgery

Study groups in NCT01832844
Study groupRoleWhat they receive
Group " with scan prior to infiltration "Active comparatorNot described
Receives: Procedure: Group " with scan prior to infiltration "
Group " without scan "Placebo comparatorPatients will have a "dummy" lumber spine evaluation in order to put patients in blind conditions
Receives: Procedure: Group " without scan "

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analogue scale measuring the pain during infiltration

    To evaluate if scan prior to epidural infiltration could improve its tolerance

    Measured: 10min after the infiltration

Secondary outcomes (10)
  1. Infiltration evaluation: procedure time between skin passage and release of the needle

    Measured: 10min after the infiltration

  2. Infiltration evaluation: attempts number before correct positioning of needle

    Measured: 10min after the infiltration

  3. Infiltration evaluation: number of puncture sites

    Measured: 10min after the infiltration

  4. Infiltration evaluation: number of failures

    Measured: 10min after the infiltration

  5. Infiltration tolerance : VAS for pain (graduating from 0 to 10)

    Measured: 48 hours

  6. Infiltration tolerance : infiltration complications (headaches, pain at the puncture site, other)

    Measured: 48 hours

  7. Distance skin- épidural space (mm) L3-L4, L4-L5 and L5-S1

    Measured: 10min after the infiltration

  8. Minimal interspinous distance (mm) L3-L4, L4-L5 and L5-S1

    Measured: 10min after the infiltration

  9. Epidural space visibility L3-L4, L4-L5 and L5-S1: 0 for " no visibility ", 1 for " mild ", 2 for " good "

    Measured: 10min after the infiltration

  10. Epidural space accessibility L3-L4, L4-L5 and L5-S1 : 0 for " no visibility ", 1 for " mild ", 2 for " good "

    Measured: 10min after the infiltration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Apr 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionJan 2014
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01832844
Sponsor's protocol ID
RC13_0096
Acronym
ECHORACHIS
Status last verified
Mar 2014
First submitted
4 Apr 2013
Last updated
24 Mar 2014
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Group " with scan prior to infiltration " and Group " without scan " in people with Sciatica, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analogue scale measuring the pain during infiltration (time frame: 10min after the infiltration). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Mar 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in